1. Home
  2. ARKO vs FTRE Comparison

ARKO vs FTRE Comparison

Compare ARKO & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ARKO Corp.

ARKO

ARKO Corp.

HOLD

Current Price

$7.47

Market Cap

737.0M

Sector

Energy

ML Signal

HOLD

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$13.31

Market Cap

829.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARKO
FTRE
Founded
1970
1996
Country
United States
United States
Employees
9748
N/A
Industry
Oil Refining/Marketing
Medical Specialities
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
737.0M
829.3M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
ARKO
FTRE
Price
$7.47
$13.31
Analyst Decision
Buy
Buy
Analyst Count
2
9
Target Price
$7.50
$14.06
AVG Volume (30 Days)
814.0K
1.5M
Earning Date
05-07-2026
05-05-2026
Dividend Yield
1.91%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,723,400,000.00
Revenue This Year
$12.86
N/A
Revenue Next Year
$1.49
$3.09
P/E Ratio
$56.88
N/A
Revenue Growth
N/A
1.00
52 Week Low
$3.71
$3.97
52 Week High
$7.50
$18.67

Technical Indicators

Market Signals
Indicator
ARKO
FTRE
Relative Strength Index (RSI) 73.28 55.18
Support Level $4.80 $8.85
Resistance Level N/A $18.26
Average True Range (ATR) 0.30 0.78
MACD 0.05 -0.23
Stochastic Oscillator 99.59 9.69

Price Performance

Historical Comparison
ARKO
FTRE

About ARKO ARKO Corp.

ARKO Corp owns and operates convenience stores in the United States. Some of its regional store brands include Stop, Admiral, Apple Market, BreadBox, E-Z Mart, fas mart, Li'l Cricket, and Next Door Store. Its retail store offers hot food service, beverages, cigarettes & other tobacco products, candy, salty snacks, grocery, beer, and general merchandise. ARKO operates in four segments: Retail segment, Wholesale segment, fleet fueling segment, and GPM Petroleum segment. It derives the majority of its revenue from retail and wholesale distribution of fuel.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: